rs143577015

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001008537.3(NEXMIF):​c.4246C>T​(p.Pro1416Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00363 in 1,209,131 control chromosomes in the GnomAD database, including 11 homozygotes. There are 1,713 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 0 hom., 94 hem., cov: 22)
Exomes 𝑓: 0.0037 ( 11 hom. 1619 hem. )

Consequence

NEXMIF
NM_001008537.3 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.79
Variant links:
Genes affected
NEXMIF (HGNC:29433): (neurite extension and migration factor) An inversion on the X chromosome which disrupts this gene and a G-protein coupled purinergic receptor gene located in the pseudoautosomal region of the X chromosome has been linked to X linked cognitive disability.[provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005046755).
BP6
Variant X-74740311-G-A is Benign according to our data. Variant chrX-74740311-G-A is described in ClinVar as [Benign]. Clinvar id is 211269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-74740311-G-A is described in Lovd as [Likely_benign]. Variant chrX-74740311-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00369 (4054/1097738) while in subpopulation MID AF= 0.021 (87/4135). AF 95% confidence interval is 0.0179. There are 11 homozygotes in gnomad4_exome. There are 1619 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 94 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEXMIFNM_001008537.3 linkc.4246C>T p.Pro1416Ser missense_variant Exon 3 of 4 ENST00000055682.12 NP_001008537.1 Q5QGS0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEXMIFENST00000055682.12 linkc.4246C>T p.Pro1416Ser missense_variant Exon 3 of 4 1 NM_001008537.3 ENSP00000055682.5 Q5QGS0
NEXMIFENST00000616200.2 linkc.4246C>T p.Pro1416Ser missense_variant Exon 3 of 5 1 ENSP00000480284.1 Q5QGS0
NEXMIFENST00000642681.2 linkc.4246C>T p.Pro1416Ser missense_variant Exon 3 of 3 ENSP00000495800.1 A0A2R8YEQ5

Frequencies

GnomAD3 genomes
AF:
0.00297
AC:
331
AN:
111339
Hom.:
0
Cov.:
22
AF XY:
0.00283
AC XY:
95
AN XY:
33561
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00210
Gnomad ASJ
AF:
0.00189
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0191
Gnomad FIN
AF:
0.000999
Gnomad MID
AF:
0.0169
Gnomad NFE
AF:
0.00420
Gnomad OTH
AF:
0.00469
GnomAD3 exomes
AF:
0.00422
AC:
772
AN:
183046
Hom.:
2
AF XY:
0.00555
AC XY:
375
AN XY:
67622
show subpopulations
Gnomad AFR exome
AF:
0.000152
Gnomad AMR exome
AF:
0.00310
Gnomad ASJ exome
AF:
0.00375
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0179
Gnomad FIN exome
AF:
0.000627
Gnomad NFE exome
AF:
0.00359
Gnomad OTH exome
AF:
0.00266
GnomAD4 exome
AF:
0.00369
AC:
4054
AN:
1097738
Hom.:
11
Cov.:
31
AF XY:
0.00446
AC XY:
1619
AN XY:
363126
show subpopulations
Gnomad4 AFR exome
AF:
0.000379
Gnomad4 AMR exome
AF:
0.00298
Gnomad4 ASJ exome
AF:
0.00356
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0189
Gnomad4 FIN exome
AF:
0.000568
Gnomad4 NFE exome
AF:
0.00301
Gnomad4 OTH exome
AF:
0.00449
GnomAD4 genome
AF:
0.00296
AC:
330
AN:
111393
Hom.:
0
Cov.:
22
AF XY:
0.00280
AC XY:
94
AN XY:
33625
show subpopulations
Gnomad4 AFR
AF:
0.000457
Gnomad4 AMR
AF:
0.00210
Gnomad4 ASJ
AF:
0.00189
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0187
Gnomad4 FIN
AF:
0.000999
Gnomad4 NFE
AF:
0.00420
Gnomad4 OTH
AF:
0.00463
Alfa
AF:
0.00364
Hom.:
162
Bravo
AF:
0.00232
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00346
AC:
10
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00386
AC:
26
ExAC
AF:
0.00459
AC:
557

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 01, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 17, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 24, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not specified Benign:3
Aug 04, 2017
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 24, 2016
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
12
DANN
Benign
0.79
DEOGEN2
Benign
0.026
T;T;.
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.63
.;T;T
MetaRNN
Benign
0.0050
T;T;T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.26
N;.;.
REVEL
Benign
0.043
Sift
Benign
0.16
T;.;.
Sift4G
Benign
0.54
T;T;.
Polyphen
0.0030
B;B;.
Vest4
0.043
MVP
0.11
MPC
0.23
ClinPred
0.0017
T
GERP RS
0.95
Varity_R
0.033
gMVP
0.054

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143577015; hg19: chrX-73960146; API